Literature DB >> 26484894

Hybrid aerogel preparations as drug delivery matrices for low water-solubility drugs.

Peter Veres1, Ana M López-Periago2, István Lázár3, Javier Saurina4, Concepción Domingo5.   

Abstract

A comprehensive study of 14 hybrid aerogels of different composition with applications in drug delivery has been carried out. The overall objective was to modulate the release behavior of drug-impregnated aerogels, from an almost instantaneous release to a semi-retarded delivery prolonged during several hours, through internal surface functionalization. The designed hybrid aerogels were composed of silica and gelatin and functionalized with either phenyl, long (16) hydrocarbon chain or methyl moiety. As model systems, three class II active agents (pKa<5.5), ibuprofen, ketoprofen and triflusal, were chosen to impregnate the aerogels. The work relied on the use of supercritical fluid technology for both the synthesis and functionalization of the hybrid aerogels, as well as for the impregnation with an active agent using supercritical CO2 as a solvent. For the impregnated aerogels, in vitro release profiles were recorded under gastric and intestinal pH-conditions using HPLC techniques. The release behavior observed for the three studied drugs was explained considering the measured dissolution profiles of the crystalline drugs, the aerogel composition and its functionalization. Such features are considered of great interest to tailor the bioavailability of drugs with low water solubility.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid drugs; Gelatin; Hybrid aerogel; Silica; Supercritical CO(2)

Mesh:

Substances:

Year:  2015        PMID: 26484894     DOI: 10.1016/j.ijpharm.2015.10.045

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Amorphization and modified release of ibuprofen by post-synthetic and solvent-free loading into tailored silica aerogels.

Authors:  Ajmal Zarinwall; Viktor Maurer; Jennifer Pierick; Victor Marcus Oldhues; Julian Cedric Porsiel; Jan Henrik Finke; Georg Garnweitner
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  Organic-inorganic hybridization for the synthesis of robust in situ hydrophobic polypropylsilsesquioxane aerogels with fast oil absorption properties.

Authors:  Ze Wu; Lei Zhang; Ji Li; Xiaolu Zhao; Chunhui Yang
Journal:  RSC Adv       Date:  2018-02-02       Impact factor: 4.036

Review 3.  Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications.

Authors:  Ranjith Kumar Kankala; Yu Shrike Zhang; Shi-Bin Wang; Chia-Hung Lee; Ai-Zheng Chen
Journal:  Adv Healthc Mater       Date:  2017-07-28       Impact factor: 9.933

4.  Alginate-Based Aerogel Particles as Drug Delivery Systems: Investigation of the Supercritical Adsorption and In Vitro Evaluations.

Authors:  Daria Lovskaya; Natalia Menshutina
Journal:  Materials (Basel)       Date:  2020-01-10       Impact factor: 3.623

5.  Mesoporous starch aerogels production as drug delivery matrices: synthesis optimization, ibuprofen loading, and release property.

Authors:  Akbar Mohammadi; Jafarsadegh Moghaddas
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

Review 6.  Supercritical Fluid Technologies for the Incorporation of Synthetic and Natural Active Compounds into Materials for Drug Formulation and Delivery.

Authors:  Katja Andrina Kravanja; Matjaž Finšgar; Željko Knez; Maša Knez Marevci
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

7.  Preparation, Characterization, and In Vitro Sustained Release Profile of Resveratrol-Loaded Silica Aerogel.

Authors:  Lili Qin; Yiwei He; Xinyu Zhao; Ting Zhang; Yao Qin; Ai Du
Journal:  Molecules       Date:  2020-06-15       Impact factor: 4.411

Review 8.  New Trends in Bio-Based Aerogels.

Authors:  Loredana Elena Nita; Alina Ghilan; Alina Gabriela Rusu; Iordana Neamtu; Aurica P Chiriac
Journal:  Pharmaceutics       Date:  2020-05-13       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.